Rank | Gene Set | Z-score |
---|---|---|
1 | viral transcription (GO:0019083) | 6.47706663 |
2 | translational termination (GO:0006415) | 6.19807354 |
3 | central nervous system myelination (GO:0022010) | 6.04760280 |
4 | axon ensheathment in central nervous system (GO:0032291) | 6.04760280 |
5 | ribosomal small subunit biogenesis (GO:0042274) | 5.59230192 |
6 | cotranslational protein targeting to membrane (GO:0006613) | 5.40975285 |
7 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.36694360 |
8 | protein targeting to ER (GO:0045047) | 5.36423055 |
9 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.19985650 |
10 | translational elongation (GO:0006414) | 5.13174432 |
11 | protein localization to endoplasmic reticulum (GO:0070972) | 5.04539888 |
12 | cellular protein complex disassembly (GO:0043624) | 4.89212012 |
13 | ribosomal large subunit biogenesis (GO:0042273) | 4.84791204 |
14 | viral life cycle (GO:0019058) | 4.82525877 |
15 | translational initiation (GO:0006413) | 4.68926941 |
16 | positive thymic T cell selection (GO:0045059) | 4.66193117 |
17 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.60579924 |
18 | negative regulation of cell killing (GO:0031342) | 4.59663354 |
19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.59663354 |
20 | immunoglobulin mediated immune response (GO:0016064) | 4.54600799 |
21 | response to muramyl dipeptide (GO:0032495) | 4.52353648 |
22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.24992237 |
23 | B cell receptor signaling pathway (GO:0050853) | 4.21807296 |
24 | protein complex disassembly (GO:0043241) | 4.21583359 |
25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.09141741 |
26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.09141741 |
27 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.09141741 |
28 | modulation by symbiont of host immune response (GO:0052553) | 4.09141741 |
29 | positive regulation by symbiont of host defense response (GO:0052509) | 4.09141741 |
30 | modulation by symbiont of host defense response (GO:0052031) | 4.09141741 |
31 | response to peptidoglycan (GO:0032494) | 4.06156962 |
32 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.04896462 |
33 | macromolecular complex disassembly (GO:0032984) | 4.04117325 |
34 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.98507956 |
35 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.85572148 |
36 | detection of bacterium (GO:0016045) | 3.80870806 |
37 | detection of other organism (GO:0098543) | 3.77263512 |
38 | maturation of SSU-rRNA (GO:0030490) | 3.75428848 |
39 | protein targeting to membrane (GO:0006612) | 3.75301486 |
40 | neuronal action potential propagation (GO:0019227) | 3.69023473 |
41 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.68081885 |
42 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.62968277 |
43 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.58529139 |
44 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.58529139 |
45 | thymic T cell selection (GO:0045061) | 3.56313120 |
46 | ribosomal small subunit assembly (GO:0000028) | 3.55568677 |
47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.55297257 |
48 | DNA deamination (GO:0045006) | 3.54628943 |
49 | positive T cell selection (GO:0043368) | 3.54176160 |
50 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.53742019 |
51 | ncRNA 3-end processing (GO:0043628) | 3.49856534 |
52 | nuclear envelope reassembly (GO:0031468) | 3.49801279 |
53 | mitotic nuclear envelope reassembly (GO:0007084) | 3.49801279 |
54 | establishment of mitochondrion localization (GO:0051654) | 3.48063381 |
55 | leukocyte aggregation (GO:0070486) | 3.41364411 |
56 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.41218908 |
57 | ensheathment of neurons (GO:0007272) | 3.39555576 |
58 | axon ensheathment (GO:0008366) | 3.39555576 |
59 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.39316282 |
60 | translation (GO:0006412) | 3.38529619 |
61 | negative regulation of granulocyte differentiation (GO:0030853) | 3.34836975 |
62 | myelination (GO:0042552) | 3.34435836 |
63 | positive regulation of protein homooligomerization (GO:0032464) | 3.34223721 |
64 | macrophage activation involved in immune response (GO:0002281) | 3.33811628 |
65 | regulation of mast cell degranulation (GO:0043304) | 3.32221497 |
66 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.30803558 |
67 | negative regulation of microtubule polymerization (GO:0031115) | 3.29428507 |
68 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.25925148 |
69 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.22484046 |
70 | embryonic process involved in female pregnancy (GO:0060136) | 3.18387192 |
71 | chaperone-mediated protein transport (GO:0072321) | 3.15834119 |
72 | T cell selection (GO:0045058) | 3.15496351 |
73 | protein maturation by protein folding (GO:0022417) | 3.14769143 |
74 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.14760936 |
75 | defense response to protozoan (GO:0042832) | 3.13328934 |
76 | B cell mediated immunity (GO:0019724) | 3.13184777 |
77 | NIK/NF-kappaB signaling (GO:0038061) | 3.13000620 |
78 | peptidyl-cysteine modification (GO:0018198) | 3.12755292 |
79 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.12048450 |
80 | synaptic vesicle maturation (GO:0016188) | 3.12005432 |
81 | termination of RNA polymerase III transcription (GO:0006386) | 3.11383347 |
82 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.11383347 |
83 | regulation of leukocyte degranulation (GO:0043300) | 3.09592871 |
84 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.09196724 |
85 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.07041254 |
86 | fatty acid elongation (GO:0030497) | 3.05167098 |
87 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.04758934 |
88 | respiratory burst (GO:0045730) | 3.04416437 |
89 | B cell homeostasis (GO:0001782) | 3.02916296 |
90 | detection of temperature stimulus (GO:0016048) | 3.02836099 |
91 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.02247329 |
92 | neutrophil activation involved in immune response (GO:0002283) | 3.01980059 |
93 | positive regulation of Rap GTPase activity (GO:0032854) | 3.00539215 |
94 | negative regulation of interleukin-12 production (GO:0032695) | 2.97605170 |
95 | mRNA catabolic process (GO:0006402) | 2.97512937 |
96 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.96303973 |
97 | response to protozoan (GO:0001562) | 2.95992963 |
98 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.92252133 |
99 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.91406908 |
100 | regulation of antigen processing and presentation (GO:0002577) | 2.90078990 |
101 | cellular response to virus (GO:0098586) | 2.88819169 |
102 | positive regulation of type 2 immune response (GO:0002830) | 2.88171039 |
103 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.86998199 |
104 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.86848028 |
105 | protein targeting (GO:0006605) | 2.86054927 |
106 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.85799121 |
107 | modulation by virus of host process (GO:0019054) | 2.85662377 |
108 | detection of external biotic stimulus (GO:0098581) | 2.85618994 |
109 | establishment of protein localization to membrane (GO:0090150) | 2.85447601 |
110 | negative thymic T cell selection (GO:0045060) | 2.85258589 |
111 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.84250253 |
112 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.83975825 |
113 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.79878975 |
114 | RNA catabolic process (GO:0006401) | 2.78103749 |
115 | positive regulation of B cell differentiation (GO:0045579) | 2.77756834 |
116 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.76910414 |
117 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.76796525 |
118 | regulation of regulated secretory pathway (GO:1903305) | 2.76561448 |
119 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.75654062 |
120 | germinal center formation (GO:0002467) | 2.74647028 |
121 | tolerance induction (GO:0002507) | 2.73835496 |
122 | regulation of necroptotic process (GO:0060544) | 2.73657376 |
123 | proteasome assembly (GO:0043248) | 2.73171469 |
124 | positive regulation of mast cell activation (GO:0033005) | 2.72272113 |
125 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.69480000 |
126 | regulation of early endosome to late endosome transport (GO:2000641) | 2.69345971 |
127 | mannose metabolic process (GO:0006013) | 2.68450057 |
128 | protein palmitoylation (GO:0018345) | 2.67907914 |
129 | cellular response to type I interferon (GO:0071357) | 2.67297815 |
130 | type I interferon signaling pathway (GO:0060337) | 2.67297815 |
131 | regulation of ARF protein signal transduction (GO:0032012) | 2.65990903 |
132 | modulation by symbiont of host cellular process (GO:0044068) | 2.65450313 |
133 | response to type I interferon (GO:0034340) | 2.64652672 |
134 | negative T cell selection (GO:0043383) | 2.63559900 |
135 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.62620417 |
136 | regulation of gamma-delta T cell activation (GO:0046643) | 2.62297798 |
137 | rRNA processing (GO:0006364) | 2.60875317 |
138 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.60494561 |
139 | establishment of protein localization to organelle (GO:0072594) | 2.60414599 |
140 | ATP synthesis coupled proton transport (GO:0015986) | 2.60156845 |
141 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.60156845 |
142 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.59240889 |
143 | positive regulation of mast cell degranulation (GO:0043306) | 2.59240889 |
144 | negative regulation of type I interferon production (GO:0032480) | 2.58923092 |
145 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.58849467 |
146 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.57677533 |
147 | regulation of monocyte differentiation (GO:0045655) | 2.57618793 |
148 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.57048695 |
149 | regulation of B cell differentiation (GO:0045577) | 2.56731508 |
150 | regulation of necrotic cell death (GO:0010939) | 2.56348936 |
151 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.55952989 |
152 | mitochondrion transport along microtubule (GO:0047497) | 2.55909373 |
153 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.55909373 |
154 | amino acid import (GO:0043090) | 2.55374805 |
155 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.54701523 |
156 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.54313024 |
157 | response to host immune response (GO:0052572) | 2.54313024 |
158 | regulation of type 2 immune response (GO:0002828) | 2.54082609 |
159 | positive regulation of interferon-alpha production (GO:0032727) | 2.53951007 |
160 | cellular protein complex localization (GO:0034629) | 2.53175271 |
161 | protein neddylation (GO:0045116) | 2.53081825 |
162 | pseudouridine synthesis (GO:0001522) | 2.53005760 |
163 | L-serine transport (GO:0015825) | 2.52603879 |
164 | cellular component biogenesis (GO:0044085) | 2.52341864 |
165 | positive regulation of B cell proliferation (GO:0030890) | 2.52142900 |
166 | myeloid dendritic cell differentiation (GO:0043011) | 2.52066412 |
167 | establishment of viral latency (GO:0019043) | 2.51854856 |
168 | negative regulation of innate immune response (GO:0045824) | 2.51621526 |
169 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.50868826 |
170 | activation of MAPKKK activity (GO:0000185) | 2.50538776 |
171 | regulation of defense response to virus by virus (GO:0050690) | 2.49749389 |
172 | mature B cell differentiation (GO:0002335) | 2.49623483 |
173 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.47929864 |
174 | rRNA metabolic process (GO:0016072) | 2.47377679 |
175 | synaptic vesicle exocytosis (GO:0016079) | 2.45446719 |
176 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.44416604 |
177 | GTP biosynthetic process (GO:0006183) | 2.44060603 |
178 | establishment of protein localization to mitochondrion (GO:0072655) | 2.43263131 |
179 | protein targeting to mitochondrion (GO:0006626) | 2.42030278 |
180 | substantia nigra development (GO:0021762) | 2.41003741 |
181 | establishment of integrated proviral latency (GO:0075713) | 2.39874501 |
182 | cell migration in hindbrain (GO:0021535) | 2.38798484 |
183 | serine transport (GO:0032329) | 2.37990415 |
184 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.37803196 |
185 | DNA strand elongation (GO:0022616) | 2.37384554 |
186 | protein localization to membrane (GO:0072657) | 2.36908778 |
187 | negative regulation of GTP catabolic process (GO:0033125) | 2.36863799 |
188 | negative regulation of GTPase activity (GO:0034260) | 2.36863799 |
189 | regulation of protein heterodimerization activity (GO:0043497) | 2.36088343 |
190 | spliceosomal snRNP assembly (GO:0000387) | 2.35566690 |
191 | cholesterol biosynthetic process (GO:0006695) | 2.33387850 |
192 | UTP biosynthetic process (GO:0006228) | 2.33218318 |
193 | neuromuscular process controlling posture (GO:0050884) | 2.31747726 |
194 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.30648873 |
195 | GDP-mannose metabolic process (GO:0019673) | 2.28363369 |
196 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.28166818 |
197 | adult walking behavior (GO:0007628) | 2.27815430 |
198 | negative regulation of neurotransmitter transport (GO:0051589) | 2.26760792 |
199 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.26295199 |
Rank | Gene Set | Z-score |
---|---|---|
1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.04608826 |
2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.74569555 |
3 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.32407411 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.32225777 |
5 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.08075941 |
6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.95856067 |
7 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.79495069 |
8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.78873677 |
9 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.77823585 |
10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.74755964 |
11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.72743802 |
12 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.71465885 |
13 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.66257583 |
14 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.63084723 |
15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.60611907 |
16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.58847978 |
17 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.54875213 |
18 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.46952743 |
19 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.38708972 |
20 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.38339420 |
21 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.35763172 |
22 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.35390050 |
23 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.33495769 |
24 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.32803993 |
25 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.24781914 |
26 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.24781914 |
27 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.24781914 |
28 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.22497145 |
29 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.19348087 |
30 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.15329398 |
31 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.13477514 |
32 | MAF_26560356_Chip-Seq_TH1_Human | 2.12973502 |
33 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.12591266 |
34 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.12286484 |
35 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.07793035 |
36 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.99774296 |
37 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.94832840 |
38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.92522493 |
39 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.92467242 |
40 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.92399931 |
41 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.91881925 |
42 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.91822815 |
43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89629687 |
44 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.88862697 |
45 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.84955045 |
46 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81984387 |
47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.78742421 |
48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76127592 |
49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75700667 |
50 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.74428079 |
51 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.71957165 |
52 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.71064497 |
53 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.70685939 |
54 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.69909420 |
55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.69412283 |
56 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.66715444 |
57 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.66557699 |
58 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.66030938 |
59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.65249405 |
60 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.64292940 |
61 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.64119172 |
62 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.62810211 |
63 | KDM2B_26808549_Chip-Seq_K562_Human | 1.62465098 |
64 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.60987476 |
65 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.59439924 |
66 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.58455187 |
67 | P68_20966046_ChIP-Seq_HELA_Human | 1.57786525 |
68 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.57669336 |
69 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.55560080 |
70 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.55020234 |
71 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.54596211 |
72 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.54073617 |
73 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.54035002 |
74 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.53172600 |
75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.53147577 |
76 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.53142520 |
77 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.51374708 |
78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51205754 |
79 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.50612432 |
80 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48730820 |
81 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.48072369 |
82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.47861329 |
83 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.46671336 |
84 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.42383206 |
85 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.41864686 |
86 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.40724765 |
87 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.39570418 |
88 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.39211674 |
89 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.37928583 |
90 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.37754277 |
91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36918907 |
92 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.36724244 |
93 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.36496136 |
94 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.36318071 |
95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.35435400 |
96 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34132733 |
97 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.32926990 |
98 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.32880067 |
99 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.32829548 |
100 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.32527181 |
101 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.31307839 |
102 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.31098279 |
103 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.30804892 |
104 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.30736571 |
105 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.30284828 |
106 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.29471867 |
107 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.29470365 |
108 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.29228887 |
109 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.28221482 |
110 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.28056885 |
111 | SPI1_23127762_ChIP-Seq_K562_Human | 1.27849064 |
112 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.26842828 |
113 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.26700350 |
114 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.26446921 |
115 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.26316071 |
116 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.25203316 |
117 | MYB_26560356_Chip-Seq_TH2_Human | 1.24469897 |
118 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.24286411 |
119 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.23963086 |
120 | MYB_26560356_Chip-Seq_TH1_Human | 1.23272819 |
121 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.21767261 |
122 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20605476 |
123 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.19927551 |
124 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.19904739 |
125 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.18915779 |
126 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.18793120 |
127 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.18430968 |
128 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.18230755 |
129 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18192917 |
130 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.17415910 |
131 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.16992124 |
132 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.16884007 |
133 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16579276 |
134 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.16497395 |
135 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16381288 |
136 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.15952346 |
137 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14976276 |
138 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.14512950 |
139 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14346306 |
140 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.13136264 |
141 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11797441 |
142 | MYC_22102868_ChIP-Seq_BL_Human | 1.11649004 |
143 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11566473 |
144 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10652736 |
145 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.10622893 |
146 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.09000035 |
147 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06597724 |
148 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06439697 |
149 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.05740266 |
150 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05725890 |
151 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05612817 |
152 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.05358389 |
153 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.05278219 |
154 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.04510424 |
155 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.04228932 |
156 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.03814612 |
157 | * CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.03402282 |
158 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.03352349 |
159 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.02481391 |
160 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.01741640 |
161 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01712152 |
162 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00855248 |
163 | SA1_27219007_Chip-Seq_Bcells_Human | 0.95949052 |
164 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.95509635 |
165 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93544635 |
166 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.93194593 |
167 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.93018539 |
168 | MAF_26560356_Chip-Seq_TH2_Human | 0.92539249 |
169 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.91116174 |
170 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.90744797 |
171 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.90368937 |
172 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.90282355 |
173 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89949166 |
174 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.89298973 |
175 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.88789930 |
176 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87670415 |
177 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.87551089 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003436_decreased_susceptibility_to | 4.17148962 |
2 | MP0009379_abnormal_foot_pigmentation | 3.88988513 |
3 | MP0003880_abnormal_central_pattern | 3.41068872 |
4 | MP0005058_abnormal_lysosome_morphology | 3.01022988 |
5 | MP0000920_abnormal_myelination | 2.91681340 |
6 | MP0001790_abnormal_immune_system | 2.89788724 |
7 | MP0005387_immune_system_phenotype | 2.89788724 |
8 | MP0001835_abnormal_antigen_presentation | 2.76787447 |
9 | MP0005671_abnormal_response_to | 2.58648064 |
10 | MP0004270_analgesia | 2.55172143 |
11 | MP0003724_increased_susceptibility_to | 2.50571046 |
12 | MP0002419_abnormal_innate_immunity | 2.46022425 |
13 | MP0003183_abnormal_peptide_metabolism | 2.39396057 |
14 | MP0005451_abnormal_body_composition | 2.39386757 |
15 | MP0005025_abnormal_response_to | 2.36377616 |
16 | MP0004947_skin_inflammation | 2.35516170 |
17 | MP0002420_abnormal_adaptive_immunity | 2.34488554 |
18 | MP0001819_abnormal_immune_cell | 2.32386199 |
19 | MP0004142_abnormal_muscle_tone | 2.26273609 |
20 | MP0009278_abnormal_bone_marrow | 2.20878473 |
21 | MP0004859_abnormal_synaptic_plasticity | 2.20400540 |
22 | MP0002148_abnormal_hypersensitivity_rea | 2.17907330 |
23 | MP0001529_abnormal_vocalization | 2.10477080 |
24 | MP0003191_abnormal_cellular_cholesterol | 2.09903850 |
25 | MP0003329_amyloid_beta_deposits | 2.06535669 |
26 | MP0005464_abnormal_platelet_physiology | 2.06483883 |
27 | MP0003303_peritoneal_inflammation | 2.05197929 |
28 | MP0003763_abnormal_thymus_physiology | 2.03920450 |
29 | MP0003172_abnormal_lysosome_physiology | 2.01847007 |
30 | MP0002064_seizures | 2.01062316 |
31 | MP0002733_abnormal_thermal_nociception | 2.00701816 |
32 | MP0002398_abnormal_bone_marrow | 1.96114801 |
33 | MP0003136_yellow_coat_color | 1.90108400 |
34 | MP0005174_abnormal_tail_pigmentation | 1.86922977 |
35 | MP0000716_abnormal_immune_system | 1.85344789 |
36 | MP0001986_abnormal_taste_sensitivity | 1.84547485 |
37 | MP0002734_abnormal_mechanical_nocicepti | 1.78976157 |
38 | MP0003300_gastrointestinal_ulcer | 1.78897936 |
39 | MP0008932_abnormal_embryonic_tissue | 1.77652493 |
40 | MP0005423_abnormal_somatic_nervous | 1.77402739 |
41 | MP0004510_myositis | 1.76161717 |
42 | MP0009785_altered_susceptibility_to | 1.75801142 |
43 | MP0001970_abnormal_pain_threshold | 1.75016244 |
44 | MP0002405_respiratory_system_inflammati | 1.73367144 |
45 | MP0001968_abnormal_touch/_nociception | 1.72931279 |
46 | MP0001533_abnormal_skeleton_physiology | 1.71310527 |
47 | MP0000462_abnormal_digestive_system | 1.69326187 |
48 | MP0002272_abnormal_nervous_system | 1.68320757 |
49 | MP0003634_abnormal_glial_cell | 1.67705477 |
50 | MP0000689_abnormal_spleen_morphology | 1.67546572 |
51 | MP0009046_muscle_twitch | 1.64850113 |
52 | MP0003635_abnormal_synaptic_transmissio | 1.63351964 |
53 | MP0004885_abnormal_endolymph | 1.62565878 |
54 | MP0004957_abnormal_blastocyst_morpholog | 1.61448786 |
55 | MP0005379_endocrine/exocrine_gland_phen | 1.61060613 |
56 | MP0010155_abnormal_intestine_physiology | 1.58687001 |
57 | MP0002229_neurodegeneration | 1.56554963 |
58 | MP0002722_abnormal_immune_system | 1.54702790 |
59 | MP0001905_abnormal_dopamine_level | 1.54346599 |
60 | MP0000955_abnormal_spinal_cord | 1.54104332 |
61 | MP0005397_hematopoietic_system_phenotyp | 1.53158873 |
62 | MP0001545_abnormal_hematopoietic_system | 1.53158873 |
63 | MP0000778_abnormal_nervous_system | 1.52673449 |
64 | MP0008260_abnormal_autophagy | 1.52360213 |
65 | MP0002429_abnormal_blood_cell | 1.50795463 |
66 | MP0001853_heart_inflammation | 1.49011996 |
67 | MP0002163_abnormal_gland_morphology | 1.48076846 |
68 | MP0004133_heterotaxia | 1.47501820 |
69 | MP0006276_abnormal_autonomic_nervous | 1.45755859 |
70 | MP0003690_abnormal_glial_cell | 1.43599744 |
71 | MP0000604_amyloidosis | 1.43002408 |
72 | MP0001348_abnormal_lacrimal_gland | 1.41206918 |
73 | MP0002653_abnormal_ependyma_morphology | 1.39077671 |
74 | MP0001485_abnormal_pinna_reflex | 1.37429236 |
75 | MP0005310_abnormal_salivary_gland | 1.37031857 |
76 | MP0002735_abnormal_chemical_nociception | 1.36976048 |
77 | MP0001486_abnormal_startle_reflex | 1.36553119 |
78 | MP0001845_abnormal_inflammatory_respons | 1.36515522 |
79 | MP0002736_abnormal_nociception_after | 1.33887944 |
80 | MP0003693_abnormal_embryo_hatching | 1.31768959 |
81 | MP0008057_abnormal_DNA_replication | 1.30217495 |
82 | MP0000703_abnormal_thymus_morphology | 1.29050934 |
83 | MP0003075_altered_response_to | 1.28844358 |
84 | MP0000858_altered_metastatic_potential | 1.27665173 |
85 | MP0005075_abnormal_melanosome_morpholog | 1.27167679 |
86 | MP0002751_abnormal_autonomic_nervous | 1.21626606 |
87 | MP0002882_abnormal_neuron_morphology | 1.19650002 |
88 | MP0008469_abnormal_protein_level | 1.19643315 |
89 | MP0004185_abnormal_adipocyte_glucose | 1.19566502 |
90 | MP0002909_abnormal_adrenal_gland | 1.19031679 |
91 | MP0009745_abnormal_behavioral_response | 1.18456698 |
92 | MP0003453_abnormal_keratinocyte_physiol | 1.17969349 |
93 | MP0002998_abnormal_bone_remodeling | 1.17732533 |
94 | MP0004742_abnormal_vestibular_system | 1.16612114 |
95 | MP0002067_abnormal_sensory_capabilities | 1.16527524 |
96 | MP0006072_abnormal_retinal_apoptosis | 1.16501469 |
97 | MP0003938_abnormal_ear_development | 1.13441153 |
98 | MP0002572_abnormal_emotion/affect_behav | 1.13424095 |
99 | MP0003283_abnormal_digestive_organ | 1.13353847 |
100 | MP0002138_abnormal_hepatobiliary_system | 1.12666575 |
101 | MP0002066_abnormal_motor_capabilities/c | 1.11851994 |
102 | MP0005409_darkened_coat_color | 1.10699823 |
103 | MP0003656_abnormal_erythrocyte_physiolo | 1.07725886 |
104 | MP0002638_abnormal_pupillary_reflex | 1.05901415 |
105 | MP0000015_abnormal_ear_pigmentation | 1.05721236 |
106 | MP0008569_lethality_at_weaning | 1.05268258 |
107 | MP0003828_pulmonary_edema | 1.04781924 |
108 | MP0003632_abnormal_nervous_system | 1.02849724 |
109 | MP0003879_abnormal_hair_cell | 1.01523500 |
110 | MP0002184_abnormal_innervation | 0.99622258 |
111 | MP0004811_abnormal_neuron_physiology | 0.99415722 |
112 | MP0000613_abnormal_salivary_gland | 0.98987336 |
113 | MP0005076_abnormal_cell_differentiation | 0.98963730 |
114 | MP0000343_altered_response_to | 0.96924276 |
115 | MP0009764_decreased_sensitivity_to | 0.94920788 |
116 | MP0001440_abnormal_grooming_behavior | 0.94324116 |
117 | MP0001873_stomach_inflammation | 0.92550848 |
118 | MP0003866_abnormal_defecation | 0.92105439 |
119 | MP0005000_abnormal_immune_tolerance | 0.91572259 |
120 | MP0002752_abnormal_somatic_nervous | 0.91547921 |
121 | MP0002152_abnormal_brain_morphology | 0.90776398 |
122 | MP0008874_decreased_physiological_sensi | 0.88447845 |
123 | MP0002063_abnormal_learning/memory/cond | 0.88358788 |
124 | MP0005166_decreased_susceptibility_to | 0.87858017 |
125 | MP0009840_abnormal_foam_cell | 0.86926100 |
126 | MP0003091_abnormal_cell_migration | 0.86598366 |
127 | MP0003705_abnormal_hypodermis_morpholog | 0.85741651 |
128 | MP0006082_CNS_inflammation | 0.85657183 |
129 | MP0001851_eye_inflammation | 0.83792972 |
130 | MP0002009_preneoplasia | 0.83779482 |
131 | MP0001800_abnormal_humoral_immune | 0.83762665 |
132 | MP0004381_abnormal_hair_follicle | 0.83430628 |
133 | MP0001663_abnormal_digestive_system | 0.81945728 |
134 | MP0004858_abnormal_nervous_system | 0.81834684 |
135 | MP0000490_abnormal_crypts_of | 0.80044825 |
136 | MP0003787_abnormal_imprinting | 0.79995722 |
137 | MP0003631_nervous_system_phenotype | 0.79785362 |
138 | MP0001849_ear_inflammation | 0.79243866 |
139 | MP0003633_abnormal_nervous_system | 0.78157567 |
140 | MP0009333_abnormal_splenocyte_physiolog | 0.78028532 |
141 | MP0002277_abnormal_respiratory_mucosa | 0.77047972 |
142 | MP0004808_abnormal_hematopoietic_stem | 0.75937506 |
143 | MP0001188_hyperpigmentation | 0.75664315 |
144 | MP0002139_abnormal_hepatobiliary_system | 0.75077699 |
145 | MP0003077_abnormal_cell_cycle | 0.74393123 |
146 | MP0002723_abnormal_immune_serum | 0.72986547 |
147 | MP0000358_abnormal_cell_content/ | 0.71810154 |
148 | MP0005666_abnormal_adipose_tissue | 0.70843381 |
149 | MP0002557_abnormal_social/conspecific_i | 0.70635766 |
150 | MP0005390_skeleton_phenotype | 0.70258763 |
151 | MP0002796_impaired_skin_barrier | 0.70029967 |
152 | MP0002452_abnormal_antigen_presenting | 0.69824511 |
153 | MP0000685_abnormal_immune_system | 0.68517936 |
154 | MP0003011_delayed_dark_adaptation | 0.67263791 |
155 | MP0003111_abnormal_nucleus_morphology | 0.66370174 |
156 | MP0003123_paternal_imprinting | 0.64992235 |
157 | MP0000350_abnormal_cell_proliferation | 0.64812936 |
158 | MP0003861_abnormal_nervous_system | 0.64465870 |
159 | MP0006292_abnormal_olfactory_placode | 0.63738079 |
160 | MP0005381_digestive/alimentary_phenotyp | 0.62155007 |
161 | MP0000249_abnormal_blood_vessel | 0.61419478 |
162 | MP0001730_embryonic_growth_arrest | 0.61396184 |
163 | MP0005535_abnormal_body_temperature | 0.60236619 |
164 | MP0000465_gastrointestinal_hemorrhage | 0.59895216 |
165 | MP0002693_abnormal_pancreas_physiology | 0.59299032 |
166 | MP0005501_abnormal_skin_physiology | 0.59253633 |
167 | MP0002089_abnormal_postnatal_growth/wei | 0.58535565 |
168 | MP0002933_joint_inflammation | 0.57891724 |
169 | MP0005621_abnormal_cell_physiology | 0.55388289 |
170 | MP0009115_abnormal_fat_cell | 0.53042039 |
171 | MP0009763_increased_sensitivity_to | 0.52316760 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 5.21121962 |
2 | Agammaglobulinemia (HP:0004432) | 4.51269406 |
3 | Abnormality of macrophages (HP:0004311) | 4.23374402 |
4 | Cellulitis (HP:0100658) | 4.16239688 |
5 | Recurrent bacterial skin infections (HP:0005406) | 4.11592693 |
6 | Mediastinal lymphadenopathy (HP:0100721) | 4.09044443 |
7 | Cerebral hypomyelination (HP:0006808) | 4.00142486 |
8 | Abnormality of glycolipid metabolism (HP:0010969) | 3.94778062 |
9 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.94778062 |
10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.94778062 |
11 | Recurrent abscess formation (HP:0002722) | 3.94375095 |
12 | Neurofibrillary tangles (HP:0002185) | 3.83996534 |
13 | Supranuclear gaze palsy (HP:0000605) | 3.81195552 |
14 | Meningitis (HP:0001287) | 3.74008498 |
15 | Chronic obstructive pulmonary disease (HP:0006510) | 3.68004530 |
16 | Obstructive lung disease (HP:0006536) | 3.68004530 |
17 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.63301004 |
18 | Recurrent fungal infections (HP:0002841) | 3.48786239 |
19 | Reticulocytopenia (HP:0001896) | 3.45450128 |
20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.43718951 |
21 | Macrocytic anemia (HP:0001972) | 3.37286605 |
22 | Gastrointestinal stroma tumor (HP:0100723) | 3.36312590 |
23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.32792774 |
24 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.32771275 |
25 | Abnormal number of erythroid precursors (HP:0012131) | 3.26942131 |
26 | Gastrointestinal inflammation (HP:0004386) | 3.21477549 |
27 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.20811475 |
28 | Abnormal hemoglobin (HP:0011902) | 3.20801697 |
29 | Increased IgE level (HP:0003212) | 3.17235129 |
30 | Colitis (HP:0002583) | 3.12498295 |
31 | Parakeratosis (HP:0001036) | 3.08858912 |
32 | Pallor (HP:0000980) | 3.07114045 |
33 | Mutism (HP:0002300) | 3.06667754 |
34 | Inflammation of the large intestine (HP:0002037) | 3.05666505 |
35 | Increased cerebral lipofuscin (HP:0011813) | 3.04081708 |
36 | Vasculitis (HP:0002633) | 2.98723467 |
37 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.97500184 |
38 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.97500184 |
39 | Peripheral hypomyelination (HP:0007182) | 2.94849088 |
40 | Concave nail (HP:0001598) | 2.91689952 |
41 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.90127294 |
42 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.89770965 |
43 | Dysostosis multiplex (HP:0000943) | 2.89269420 |
44 | Neuronal loss in central nervous system (HP:0002529) | 2.85376082 |
45 | Retinal dysplasia (HP:0007973) | 2.84505682 |
46 | Verrucae (HP:0200043) | 2.84280971 |
47 | Papilloma (HP:0012740) | 2.84280971 |
48 | Myositis (HP:0100614) | 2.81665107 |
49 | Cerebral inclusion bodies (HP:0100314) | 2.81472060 |
50 | Recurrent skin infections (HP:0001581) | 2.81061309 |
51 | Obstructive sleep apnea (HP:0002870) | 2.79892758 |
52 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.72950110 |
53 | Recurrent cutaneous fungal infections (HP:0011370) | 2.72950110 |
54 | Urticaria (HP:0001025) | 2.71393874 |
55 | Recurrent viral infections (HP:0004429) | 2.69002477 |
56 | Hypercortisolism (HP:0001578) | 2.64879538 |
57 | Hemorrhage of the eye (HP:0011885) | 2.61238520 |
58 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.60573556 |
59 | Panhypogammaglobulinemia (HP:0003139) | 2.59852781 |
60 | Orchitis (HP:0100796) | 2.59077639 |
61 | Purpura (HP:0000979) | 2.58087950 |
62 | Type II lissencephaly (HP:0007260) | 2.53893452 |
63 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.52828277 |
64 | Spontaneous hematomas (HP:0007420) | 2.45369406 |
65 | Polygenic inheritance (HP:0010982) | 2.44002294 |
66 | Increased hepatocellular lipid droplets (HP:0006565) | 2.43835899 |
67 | Abnormality of the corticospinal tract (HP:0002492) | 2.42891702 |
68 | Osteomyelitis (HP:0002754) | 2.42841721 |
69 | Split foot (HP:0001839) | 2.41462681 |
70 | Lymphopenia (HP:0001888) | 2.40966145 |
71 | Restrictive lung disease (HP:0002091) | 2.39944007 |
72 | Encephalitis (HP:0002383) | 2.39710922 |
73 | Increased IgM level (HP:0003496) | 2.38965215 |
74 | Progressive neurologic deterioration (HP:0002344) | 2.38751064 |
75 | Optic neuritis (HP:0100653) | 2.37665000 |
76 | Retrobulbar optic neuritis (HP:0100654) | 2.37665000 |
77 | Visual hallucinations (HP:0002367) | 2.36876221 |
78 | CNS hypomyelination (HP:0003429) | 2.36858678 |
79 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.36673660 |
80 | Asplenia (HP:0001746) | 2.32221101 |
81 | Recurrent sinusitis (HP:0011108) | 2.31068362 |
82 | Recurrent bronchitis (HP:0002837) | 2.31068234 |
83 | Pustule (HP:0200039) | 2.30979240 |
84 | Exertional dyspnea (HP:0002875) | 2.28850486 |
85 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.28567723 |
86 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.27923211 |
87 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.27923211 |
88 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.27784213 |
89 | Myokymia (HP:0002411) | 2.27109106 |
90 | Prolonged bleeding time (HP:0003010) | 2.26591303 |
91 | Recurrent pneumonia (HP:0006532) | 2.26390133 |
92 | Systemic lupus erythematosus (HP:0002725) | 2.25266304 |
93 | Hypochromic anemia (HP:0001931) | 2.24733851 |
94 | Gastrointestinal infarctions (HP:0005244) | 2.23363947 |
95 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.23142305 |
96 | Emphysema (HP:0002097) | 2.22490395 |
97 | Recurrent lower respiratory tract infections (HP:0002783) | 2.21986341 |
98 | Gingivitis (HP:0000230) | 2.21703643 |
99 | Deep palmar crease (HP:0006191) | 2.21296285 |
100 | Hyperphosphatemia (HP:0002905) | 2.20302613 |
101 | Thoracic kyphosis (HP:0002942) | 2.19569202 |
102 | Sepsis (HP:0100806) | 2.19316618 |
103 | Increased intramyocellular lipid droplets (HP:0012240) | 2.18703330 |
104 | Epistaxis (HP:0000421) | 2.18083459 |
105 | Pulmonary infiltrates (HP:0002113) | 2.15789345 |
106 | Sensory axonal neuropathy (HP:0003390) | 2.14493671 |
107 | Clumsiness (HP:0002312) | 2.12428728 |
108 | Stenosis of the external auditory canal (HP:0000402) | 2.11844423 |
109 | Petechiae (HP:0000967) | 2.11780195 |
110 | Spastic gait (HP:0002064) | 2.09519746 |
111 | Achilles tendon contracture (HP:0001771) | 2.08965637 |
112 | Alacrima (HP:0000522) | 2.07490990 |
113 | Hypertensive crisis (HP:0100735) | 2.07067458 |
114 | Postnatal microcephaly (HP:0005484) | 2.06603949 |
115 | Renal Fanconi syndrome (HP:0001994) | 2.05215185 |
116 | Growth hormone excess (HP:0000845) | 2.04586820 |
117 | Abnormal large intestine physiology (HP:0012700) | 2.04456973 |
118 | Increased serum ferritin (HP:0003281) | 2.02834790 |
119 | Flat occiput (HP:0005469) | 2.02671118 |
120 | Broad face (HP:0000283) | 2.01596455 |
121 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.00478970 |
122 | Bowel incontinence (HP:0002607) | 1.98484945 |
123 | Diminished motivation (HP:0000745) | 1.96150640 |
124 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.94364322 |
125 | Mitochondrial inheritance (HP:0001427) | 1.93483913 |
126 | Emotional lability (HP:0000712) | 1.93398071 |
127 | Slow saccadic eye movements (HP:0000514) | 1.93017588 |
128 | Lipid accumulation in hepatocytes (HP:0006561) | 1.91514046 |
129 | Ankle clonus (HP:0011448) | 1.91507081 |
130 | Abnormality of the thoracic spine (HP:0100711) | 1.90102131 |
131 | Cerebellar dysplasia (HP:0007033) | 1.89591481 |
132 | Hemoptysis (HP:0002105) | 1.88675799 |
133 | Loss of speech (HP:0002371) | 1.88414297 |
134 | Skin rash (HP:0000988) | 1.86414890 |
135 | Delusions (HP:0000746) | 1.86014985 |
136 | Restlessness (HP:0000711) | 1.85906800 |
137 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.85630003 |
138 | Apathy (HP:0000741) | 1.85245190 |
139 | Dysautonomia (HP:0002459) | 1.85096559 |
140 | Orthostatic hypotension (HP:0001278) | 1.85049932 |
141 | Hepatocellular necrosis (HP:0001404) | 1.84708196 |
142 | Partial duplication of thumb phalanx (HP:0009944) | 1.82563859 |
143 | Long palpebral fissure (HP:0000637) | 1.82061085 |
144 | Gingival bleeding (HP:0000225) | 1.82032501 |
145 | Viral hepatitis (HP:0006562) | 1.81014367 |
146 | Absent radius (HP:0003974) | 1.80201263 |
147 | Rough bone trabeculation (HP:0100670) | 1.80053941 |
148 | External ophthalmoplegia (HP:0000544) | 1.80001221 |
149 | Dysmetria (HP:0001310) | 1.79621367 |
150 | Progressive inability to walk (HP:0002505) | 1.78756489 |
151 | Skin ulcer (HP:0200042) | 1.78441004 |
152 | Spastic paraparesis (HP:0002313) | 1.78339146 |
153 | Hepatosplenomegaly (HP:0001433) | 1.78012640 |
154 | Anteriorly placed anus (HP:0001545) | 1.77817318 |
155 | Vacuolated lymphocytes (HP:0001922) | 1.77545464 |
156 | Leukodystrophy (HP:0002415) | 1.77316172 |
157 | Personality changes (HP:0000751) | 1.77315935 |
158 | Akinesia (HP:0002304) | 1.77159147 |
159 | Hyperparathyroidism (HP:0000843) | 1.76614260 |
160 | Autoimmune thrombocytopenia (HP:0001973) | 1.76222601 |
161 | J-shaped sella turcica (HP:0002680) | 1.75593466 |
162 | Urinary incontinence (HP:0000020) | 1.75267730 |
163 | Amyloidosis (HP:0011034) | 1.75162343 |
164 | Stomatitis (HP:0010280) | 1.75079933 |
165 | Abnormality of the peritoneum (HP:0002585) | 1.74982104 |
166 | Megalencephaly (HP:0001355) | 1.74741115 |
167 | Absent forearm bone (HP:0003953) | 1.73984344 |
168 | Aplasia involving forearm bones (HP:0009822) | 1.73984344 |
169 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.71275759 |
170 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.71275759 |
171 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.71275759 |
172 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.71005706 |
173 | Hypoplastic pelvis (HP:0008839) | 1.70823243 |
174 | Partial duplication of the phalanx of hand (HP:0009999) | 1.69804692 |
175 | Decreased lacrimation (HP:0000633) | 1.68648869 |
176 | Mucopolysacchariduria (HP:0008155) | 1.67302922 |
177 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.67302922 |
178 | Overlapping toe (HP:0001845) | 1.66313319 |
179 | Hemiparesis (HP:0001269) | 1.65708231 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TLK1 | 4.42530691 |
2 | CDK19 | 3.74971586 |
3 | PRPF4B | 3.57989454 |
4 | MAP3K10 | 3.53466041 |
5 | ERN1 | 3.34636098 |
6 | TESK2 | 2.85324584 |
7 | BLK | 2.70144167 |
8 | MAP3K9 | 2.56051677 |
9 | MAPK15 | 2.46099197 |
10 | STK39 | 2.39475658 |
11 | MAP2K3 | 2.38141550 |
12 | BUB1 | 2.33338783 |
13 | TRIB3 | 2.31620540 |
14 | UHMK1 | 2.22233133 |
15 | SCYL2 | 2.12803270 |
16 | NTRK1 | 1.97279617 |
17 | EIF2AK1 | 1.87746537 |
18 | IRAK4 | 1.87219813 |
19 | OXSR1 | 1.85313980 |
20 | FES | 1.84041824 |
21 | MAPKAPK5 | 1.83633720 |
22 | RIPK1 | 1.80051695 |
23 | TBK1 | 1.77731162 |
24 | TAOK1 | 1.74412718 |
25 | PNCK | 1.71038257 |
26 | TAOK2 | 1.69241560 |
27 | DYRK3 | 1.68728016 |
28 | NME2 | 1.64044111 |
29 | SIK1 | 1.59900274 |
30 | PBK | 1.56368232 |
31 | RIPK4 | 1.54965289 |
32 | MAP3K3 | 1.52037302 |
33 | STK16 | 1.51909226 |
34 | PRKD2 | 1.51511993 |
35 | KSR2 | 1.49111209 |
36 | MAP3K13 | 1.47425732 |
37 | IRAK3 | 1.44261394 |
38 | ARAF | 1.41779768 |
39 | TYK2 | 1.38548507 |
40 | SIK2 | 1.38270721 |
41 | FGR | 1.35010646 |
42 | MATK | 1.31776424 |
43 | CLK1 | 1.31356433 |
44 | SMG1 | 1.30804501 |
45 | CDK12 | 1.29531823 |
46 | BTK | 1.26051223 |
47 | WEE1 | 1.25251052 |
48 | IKBKE | 1.23923164 |
49 | ACVR1B | 1.22405823 |
50 | ZAP70 | 1.20600978 |
51 | LIMK1 | 1.16129502 |
52 | DYRK2 | 1.15621810 |
53 | VRK1 | 1.14266886 |
54 | MAP3K14 | 1.13499967 |
55 | CDC42BPA | 1.12085041 |
56 | EPHB1 | 1.09415059 |
57 | MAP2K2 | 1.06577623 |
58 | MAP3K11 | 1.05181696 |
59 | CDK14 | 1.04645609 |
60 | BMPR2 | 1.04186741 |
61 | IKBKB | 1.02878808 |
62 | BRAF | 1.01199607 |
63 | CSNK1G3 | 0.98360747 |
64 | PAK6 | 0.97681016 |
65 | GRK5 | 0.97670031 |
66 | CSF1R | 0.97633011 |
67 | PIM2 | 0.97335414 |
68 | PDPK1 | 0.94105089 |
69 | FGFR4 | 0.92796000 |
70 | RPS6KC1 | 0.92255087 |
71 | RPS6KL1 | 0.92255087 |
72 | HCK | 0.90485701 |
73 | PIM1 | 0.90309208 |
74 | MAPK12 | 0.88531028 |
75 | DAPK2 | 0.88015349 |
76 | CDK11A | 0.86896651 |
77 | ITK | 0.86694711 |
78 | DAPK3 | 0.85429492 |
79 | MARK2 | 0.85065725 |
80 | PDK1 | 0.84374814 |
81 | AURKA | 0.83233257 |
82 | CDK15 | 0.82352054 |
83 | ALK | 0.81468009 |
84 | SIK3 | 0.80959644 |
85 | ICK | 0.80175381 |
86 | STK38 | 0.78076969 |
87 | YES1 | 0.78000617 |
88 | HIPK2 | 0.76964396 |
89 | TNIK | 0.76375445 |
90 | TNK2 | 0.75457421 |
91 | RPS6KA6 | 0.73773560 |
92 | CDK18 | 0.73277650 |
93 | PAK1 | 0.70561885 |
94 | RPS6KA2 | 0.69864700 |
95 | NME1 | 0.69289916 |
96 | WNK4 | 0.69220103 |
97 | IRAK2 | 0.68912209 |
98 | JAK2 | 0.68592880 |
99 | WNK1 | 0.67791395 |
100 | CDK8 | 0.67630598 |
101 | CAMK2B | 0.66945446 |
102 | CAMKK1 | 0.65990275 |
103 | DYRK1B | 0.65379588 |
104 | BCR | 0.64923688 |
105 | MAPK11 | 0.64758112 |
106 | CSNK1G2 | 0.64448052 |
107 | SGK3 | 0.64054692 |
108 | TEC | 0.63822332 |
109 | STK11 | 0.63439452 |
110 | MARK3 | 0.63207326 |
111 | TXK | 0.62725470 |
112 | MAP4K1 | 0.62437802 |
113 | PKN1 | 0.62360228 |
114 | JAK3 | 0.61782087 |
115 | CDK5 | 0.61357652 |
116 | MET | 0.61316029 |
117 | PASK | 0.61019456 |
118 | DYRK1A | 0.60253472 |
119 | RAF1 | 0.59633613 |
120 | GRK7 | 0.59072399 |
121 | CDK6 | 0.58812671 |
122 | MINK1 | 0.58451230 |
123 | GRK6 | 0.57795063 |
124 | EIF2AK3 | 0.57361089 |
125 | MAPKAPK3 | 0.57286623 |
126 | CSNK1G1 | 0.57267032 |
127 | LMTK2 | 0.56679694 |
128 | CASK | 0.56212711 |
129 | MAP3K5 | 0.56189638 |
130 | CDK4 | 0.54894133 |
131 | TAOK3 | 0.54118286 |
132 | IRAK1 | 0.53590887 |
133 | NTRK3 | 0.51410084 |
134 | CSNK1A1L | 0.50572982 |
135 | KIT | 0.49694175 |
136 | CSNK2A2 | 0.47856488 |
137 | LCK | 0.47244636 |
138 | CHUK | 0.47065902 |
139 | DAPK1 | 0.46179878 |
140 | ROCK2 | 0.45976442 |
141 | SYK | 0.45590430 |
142 | RPS6KA5 | 0.45305407 |
143 | CDK9 | 0.44684602 |
144 | RPS6KA1 | 0.44657797 |
145 | JAK1 | 0.44069071 |
146 | MOS | 0.43387371 |
147 | CDK7 | 0.43191602 |
148 | ABL2 | 0.42314213 |
149 | TYRO3 | 0.41492945 |
150 | MAP3K8 | 0.40525901 |
151 | CAMK2D | 0.38967852 |
152 | PRKCH | 0.38916764 |
153 | FLT3 | 0.38858490 |
154 | MARK1 | 0.38580460 |
155 | MAP3K1 | 0.38249014 |
156 | FGFR3 | 0.38132489 |
157 | LRRK2 | 0.37967129 |
158 | CSK | 0.37475279 |
159 | LYN | 0.34205455 |
160 | PLK1 | 0.33307049 |
161 | MAP3K2 | 0.32210963 |
162 | MAPK10 | 0.31509599 |
163 | CSNK1E | 0.31426699 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 5.28810338 |
2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.25769592 |
3 | Allograft rejection_Homo sapiens_hsa05330 | 2.76613703 |
4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.68858163 |
5 | RNA polymerase_Homo sapiens_hsa03020 | 2.66632359 |
6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.55307355 |
7 | Asthma_Homo sapiens_hsa05310 | 2.52221522 |
8 | DNA replication_Homo sapiens_hsa03030 | 2.48885689 |
9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.46720328 |
10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.42919008 |
11 | Mismatch repair_Homo sapiens_hsa03430 | 2.34573978 |
12 | Protein export_Homo sapiens_hsa03060 | 2.34222204 |
13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.30009521 |
14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.25435221 |
15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.12568158 |
16 | Spliceosome_Homo sapiens_hsa03040 | 2.10493912 |
17 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.03903023 |
18 | Homologous recombination_Homo sapiens_hsa03440 | 1.96300428 |
19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.96252258 |
20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.94582063 |
21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.92932670 |
22 | Viral myocarditis_Homo sapiens_hsa05416 | 1.77361982 |
23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.76441120 |
24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.75409374 |
25 | Sulfur relay system_Homo sapiens_hsa04122 | 1.68674687 |
26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.65146182 |
27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.64020522 |
28 | Lysosome_Homo sapiens_hsa04142 | 1.59819565 |
29 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.55765018 |
30 | Proteasome_Homo sapiens_hsa03050 | 1.55487417 |
31 | Base excision repair_Homo sapiens_hsa03410 | 1.54262082 |
32 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.51025222 |
33 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.50298130 |
34 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.49645932 |
35 | Influenza A_Homo sapiens_hsa05164 | 1.47073243 |
36 | Alzheimers disease_Homo sapiens_hsa05010 | 1.42837856 |
37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.42715548 |
38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.39072347 |
39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.38743075 |
40 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.38482107 |
41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37761610 |
42 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.35759177 |
43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.35753271 |
44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.34892984 |
45 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.34639721 |
46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.33668386 |
47 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.32406301 |
48 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.31995579 |
49 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.31094704 |
50 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.30895249 |
51 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.30351055 |
52 | Huntingtons disease_Homo sapiens_hsa05016 | 1.26247316 |
53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.24164032 |
54 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.20726397 |
55 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.18274956 |
56 | Hepatitis B_Homo sapiens_hsa05161 | 1.17455389 |
57 | Long-term depression_Homo sapiens_hsa04730 | 1.15688521 |
58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.15247698 |
59 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.12445208 |
60 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.11383763 |
61 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.10414081 |
62 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.06530015 |
63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.06251289 |
64 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.03381394 |
65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03181120 |
66 | Hepatitis C_Homo sapiens_hsa05160 | 1.02453599 |
67 | RNA transport_Homo sapiens_hsa03013 | 1.01076624 |
68 | Apoptosis_Homo sapiens_hsa04210 | 1.00625727 |
69 | Alcoholism_Homo sapiens_hsa05034 | 0.99923493 |
70 | Measles_Homo sapiens_hsa05162 | 0.96632436 |
71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.95227318 |
72 | Endocytosis_Homo sapiens_hsa04144 | 0.92798733 |
73 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.92121087 |
74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.91895644 |
75 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.91558890 |
76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.90642262 |
77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89292740 |
78 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.88016380 |
79 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.87405222 |
80 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.82617642 |
81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.81673261 |
82 | Cocaine addiction_Homo sapiens_hsa05030 | 0.79443801 |
83 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.79311472 |
84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78862942 |
85 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.78202543 |
86 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.77986920 |
87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.77669861 |
88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77534960 |
89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77314303 |
90 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75500044 |
91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75291858 |
92 | Malaria_Homo sapiens_hsa05144 | 0.74634752 |
93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74577927 |
94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.74173914 |
95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73858665 |
96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.73637849 |
97 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72849777 |
98 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70314970 |
99 | Legionellosis_Homo sapiens_hsa05134 | 0.69157528 |
100 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.69081155 |
101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68923068 |
102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68272227 |
103 | Long-term potentiation_Homo sapiens_hsa04720 | 0.67936028 |
104 | Axon guidance_Homo sapiens_hsa04360 | 0.67636585 |
105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.66888120 |
106 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.66886930 |
107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65635697 |
108 | Basal transcription factors_Homo sapiens_hsa03022 | 0.65348243 |
109 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.64075664 |
110 | Prion diseases_Homo sapiens_hsa05020 | 0.63738032 |
111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63572627 |
112 | Phagosome_Homo sapiens_hsa04145 | 0.63241902 |
113 | Shigellosis_Homo sapiens_hsa05131 | 0.62749129 |
114 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62381964 |
115 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.61684710 |
116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61448228 |
117 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61098621 |
118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59492430 |
119 | GABAergic synapse_Homo sapiens_hsa04727 | 0.58325462 |
120 | Gap junction_Homo sapiens_hsa04540 | 0.56491484 |
121 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.55882476 |
122 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55424303 |
123 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54370344 |
124 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54019561 |
125 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.52785636 |
126 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52634128 |
127 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.52573943 |
128 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52032688 |
129 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51548283 |
130 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.51461248 |
131 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.50199625 |
132 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49730457 |
133 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.49152031 |
134 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49128167 |
135 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48236642 |
136 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48133493 |
137 | Platelet activation_Homo sapiens_hsa04611 | 0.47179586 |
138 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46438961 |
139 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.46217139 |
140 | Tuberculosis_Homo sapiens_hsa05152 | 0.45899275 |
141 | Bladder cancer_Homo sapiens_hsa05219 | 0.45890080 |
142 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45789653 |
143 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.45367705 |
144 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45265762 |
145 | Purine metabolism_Homo sapiens_hsa00230 | 0.44710594 |
146 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42335223 |
147 | Salmonella infection_Homo sapiens_hsa05132 | 0.41552782 |
148 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41445097 |
149 | Morphine addiction_Homo sapiens_hsa05032 | 0.41324795 |
150 | Pertussis_Homo sapiens_hsa05133 | 0.41257540 |
151 | Prostate cancer_Homo sapiens_hsa05215 | 0.41155345 |
152 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41083990 |
153 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.40957655 |
154 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40934993 |
155 | Cell cycle_Homo sapiens_hsa04110 | 0.40907375 |
156 | Nicotine addiction_Homo sapiens_hsa05033 | 0.40382782 |
157 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.40098887 |
158 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39568111 |
159 | Glioma_Homo sapiens_hsa05214 | 0.38903056 |
160 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.37947349 |
161 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37938644 |
162 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35146531 |
163 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.34895513 |
164 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33992753 |
165 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.33949010 |